Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Zhou, Huangyana; b; c | Yuan, Mind | Yu, Qiongfange | Zhou, Xiaoyanf | Min, Weipinga; b; c | Gao, Diana; b; c; *
Affiliations: [a] Department of Pathogen Biology and Immunology, Medical College of Nanchang University, Nanchang, Jiangxi, China | [b] Jiangxi Academy of Medical Sciences, Nanchang, Jiangxi, China | [c] Institute of Immunotherapy, Nanchang University, Nanchang, Jiangxi, China | [d] Department of Neurology, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China | [e] Department of Gastroenterology and Hepatology, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China | [f] Department of Pathophysiology, Medical College of Nanchang University, Nanchang, Jiangxi, China
Correspondence: [*] Corresponding author: Dian Gao, Department of Pathogen Biology and Immunology, Medical College of Nanchang University, 461 Bayi Road, Nanchang 330006, Jiangxi, China. Tel.: +86 0791 86360556; E-mail:gaodian@ncu.edu.cn
Abstract: BACKGROUND: Autophagy is associated with the occurrence, development, cellular adaptation, progression, treatment and prognosis of gastric cancer (GC) and colorectal cancer (CRC). The effect of autophagy in these two cancers has attracted our attention. OBJECTIVE: The aim of this study was to describe the functional and regulatory mechanisms associated with autophagy in GC and CRC. METHODS: We reviewed recent publications describing the role of autophagy in GC and CRC, including the functional characteristics, clinical significance and regulatory mechanisms. RESULTS: Autophagy plays context-dependent dual roles in the development and progression of GC and CRC. It can either promote tumor growth and cell survival or can contribute to tumor suppression and promote cell death. Both of these effects employ complex regulatory networks, such as those mediated by p53, PI3K/Akt/mTOR, Ras and microRNA. Among the cellular process associated with these pathways, autophagy is a potential target for anti-tumor therapy. CONCLUSION: Autophagy is associated with both tumorigenic and protective effects in cancer. However, the role of autophagy in GC and CRC remains unclear. Although the translation of the basic science of autophagy into clinical practice is a long process, the modulation of autophagy as a potential therapeutic approach in GC and CRC merits further investigation.
Keywords: Autophagy, gastric cancer, colorectal cancer
DOI: 10.3233/CBM-160613
Journal: Cancer Biomarkers, vol. 17, no. 1, pp. 1-10, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl